ObtusinCAS# 70588-05-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 70588-05-5 | SDF | Download SDF |
| PubChem ID | 155380 | Appearance | Powder |
| Formula | C18H16O7 | M.Wt | 344.3 |
| Type of Compound | Anthraquinones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1,7-dihydroxy-2,3,8-trimethoxy-6-methylanthracene-9,10-dione | ||
| SMILES | CC1=C(C(=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)OC)OC)OC)O | ||
| Standard InChIKey | CFLNHFUPWNRWJA-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C18H16O7/c1-7-5-8-12(18(25-4)13(7)19)15(21)11-9(14(8)20)6-10(23-2)17(24-3)16(11)22/h5-6,19,22H,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| In vitro | Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase.[Pubmed: 17978503]Biol Pharm Bull. 2007 Nov;30(11):2207-10.
|
Obtusin Dilution Calculator
Obtusin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9044 mL | 14.5222 mL | 29.0444 mL | 58.0889 mL | 72.6111 mL |
| 5 mM | 0.5809 mL | 2.9044 mL | 5.8089 mL | 11.6178 mL | 14.5222 mL |
| 10 mM | 0.2904 mL | 1.4522 mL | 2.9044 mL | 5.8089 mL | 7.2611 mL |
| 50 mM | 0.0581 mL | 0.2904 mL | 0.5809 mL | 1.1618 mL | 1.4522 mL |
| 100 mM | 0.029 mL | 0.1452 mL | 0.2904 mL | 0.5809 mL | 0.7261 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Shizukanolide A
Catalog No.:BCN8021
CAS No.:70578-36-8
- Yunaconitine
Catalog No.:BCN6261
CAS No.:70578-24-4
- Herbimycin A
Catalog No.:BCC7132
CAS No.:70563-58-5
- Daurisoline
Catalog No.:BCN2675
CAS No.:70553-76-3
- Aflatrem
Catalog No.:BCN7414
CAS No.:70553-75-2
- NS 3763
Catalog No.:BCC7275
CAS No.:70553-45-6
- α-Conotoxin PnIA
Catalog No.:BCC5978
CAS No.:705300-84-1
- 3,5-Dimethoxybenzylalcohol
Catalog No.:BCN3760
CAS No.:705-76-0
- 2'-Hydroxy-5'-methoxyacetophenone
Catalog No.:BCN4270
CAS No.:705-15-7
- ARP 100
Catalog No.:BCC2370
CAS No.:704888-90-4
- Mitoxantrone HCl
Catalog No.:BCC4924
CAS No.:70476-82-3
- Petasinoside
Catalog No.:BCN1989
CAS No.:70474-34-9
- Chrysoobtusin
Catalog No.:BCC8309
CAS No.:70588-06-6
- 19alpha-Hydroxyfern-7-ene
Catalog No.:BCN7405
CAS No.:70588-12-4
- 14beta-Benzoyloxy-2-deacetylbaccatin VI
Catalog No.:BCN1373
CAS No.:705973-69-9
- Phlorizin dihydrate
Catalog No.:BCN2584
CAS No.:7061-54-3
- Boc-D-Tyr-OH
Catalog No.:BCC3463
CAS No.:70642-86-3
- Anisotropine Methylbromide; Octatropine Methylbromide
Catalog No.:BCC8120
CAS No.:70642-90-9
- Z-D-Lys-OH
Catalog No.:BCC2761
CAS No.:70671-54-4
- Catharanthine Sulfate
Catalog No.:BCN3859
CAS No.:70674-90-7
- Canniprene
Catalog No.:BCN4271
CAS No.:70677-47-3
- Pimavanserin
Catalog No.:BCC8065
CAS No.:706779-91-1
- 3-Chlorotyrosine
Catalog No.:BCC2639
CAS No.:70680-93-2
- H-D-Ala(3-pyridyl)-OH.HCl
Catalog No.:BCC3323
CAS No.:70702-47-5
Medicinal plant phytochemicals and their inhibitory activities against pancreatic lipase: molecular docking combined with molecular dynamics simulation approach.[Pubmed:28446025]
Nat Prod Res. 2018 May;32(10):1123-1129.
Obesity is the worst health risk worldwide, which is linked to a number of diseases. Pancreatic lipase is considered as an affective cause of obesity and can be a major target for controlling the obesity. The present study was designed to find out best phytochemicals against pancreatic lipase through molecular docking combined with molecular dynamics (MD) simulation. For this purpose, a total of 3770 phytochemicals were docked against pancreatic lipase and ranked them on the basis of binding affinity. Finally, 10 molecules (Kushenol K, Rosmarinic acid, Reserpic acid, Munjistin, Leachianone G, Cephamycin C, Arctigenin, 3-O-acetylpadmatin, Geniposide and Obtusin) were selected that showed strong bonding with the pancreatic lipase. MD simulations were performed on top five compounds using AMBER16. The simulated complexes revealed stability and ligands remained inside the binding pocket. This study concluded that these finalised molecules can be used as drug candidate to control obesity.
